发明授权
US6117840A CS-1 peptidomimetics, compositions and methods of using the same 失效
CS-1肽模拟物,组合物和使用它们的方法

CS-1 peptidomimetics, compositions and methods of using the same
摘要:
The present invention contemplates a peptide that inhibits the binding between the VLA-4 receptor expressed on inflammatory leukocytes and the fibronectin CS-1 peptide expressed on endothelial cells that are involved in immunoinflammatory disease states. Pharmaceutical compositions containing a contemplated peptide and processes for treating immunoinflammatory conditions using a binding-inhibitory peptide are also disclosed.
公开/授权文献
信息查询
0/0